
Robert E. Mosser
Examiner (ID: 16617, Phone: (571)272-4451 , Office: P/3714 )
| Most Active Art Unit | 3715 |
| Art Unit(s) | 3714, 3715, 3713, 3712 |
| Total Applications | 839 |
| Issued Applications | 347 |
| Pending Applications | 141 |
| Abandoned Applications | 372 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11798518
[patent_doc_number] => 09539235
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-01-10
[patent_title] => 'Methods for Alzheimer\'s disease treatment and cognitive enhancement'
[patent_app_type] => utility
[patent_app_number] => 13/851161
[patent_app_country] => US
[patent_app_date] => 2013-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 9
[patent_no_of_words] => 9022
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13851161
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/851161 | Methods for Alzheimer's disease treatment and cognitive enhancement | Mar 26, 2013 | Issued |
Array
(
[id] => 13253273
[patent_doc_number] => 10139320
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-11-27
[patent_title] => Composition for processing histological, postmortem, cytological samples
[patent_app_type] => utility
[patent_app_number] => 14/388754
[patent_app_country] => US
[patent_app_date] => 2013-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2780
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14388754
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/388754 | Composition for processing histological, postmortem, cytological samples | Mar 24, 2013 | Issued |
Array
(
[id] => 10587606
[patent_doc_number] => 09309208
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-04-12
[patent_title] => 'Methods of making and using thioxothiazolidine and rhodanine derivatives as HIV-1 and JSP-1 inhibitors'
[patent_app_type] => utility
[patent_app_number] => 13/849339
[patent_app_country] => US
[patent_app_date] => 2013-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 19
[patent_no_of_words] => 5913
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13849339
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/849339 | Methods of making and using thioxothiazolidine and rhodanine derivatives as HIV-1 and JSP-1 inhibitors | Mar 21, 2013 | Issued |
Array
(
[id] => 9192135
[patent_doc_number] => 20130331450
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-12
[patent_title] => 'CLASS II HMG-COA REDUCTASE INHIBITORS AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 13/836743
[patent_app_country] => US
[patent_app_date] => 2013-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 12461
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13836743
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/836743 | Class II HMG-COA reductase inhibitors and methods of use | Mar 14, 2013 | Issued |
Array
(
[id] => 9932150
[patent_doc_number] => 20150080342
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-03-19
[patent_title] => 'BENZOXABOROLE COMPOUNDS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/394427
[patent_app_country] => US
[patent_app_date] => 2013-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 13870
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14394427
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/394427 | BENZOXABOROLE COMPOUNDS AND USES THEREOF | Mar 14, 2013 | Abandoned |
Array
(
[id] => 15510217
[patent_doc_number] => 10561675
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-02-18
[patent_title] => Cyclic boronic acid ester derivatives and therapeutic uses thereof
[patent_app_type] => utility
[patent_app_number] => 13/843579
[patent_app_country] => US
[patent_app_date] => 2013-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 16553
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13843579
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/843579 | Cyclic boronic acid ester derivatives and therapeutic uses thereof | Mar 14, 2013 | Issued |
Array
(
[id] => 9771103
[patent_doc_number] => 20140294766
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-02
[patent_title] => 'Anti-Infective Agents and Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 13/838223
[patent_app_country] => US
[patent_app_date] => 2013-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 87736
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13838223
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/838223 | Anti-infective agents and uses thereof | Mar 14, 2013 | Issued |
Array
(
[id] => 9422425
[patent_doc_number] => 20140107076
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-04-17
[patent_title] => 'CRYSTALLIZATION METHOD AND BIOAVAILABILITY'
[patent_app_type] => utility
[patent_app_number] => 13/826691
[patent_app_country] => US
[patent_app_date] => 2013-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 39
[patent_no_of_words] => 10838
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13826691
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/826691 | Crystallization method and bioavailability | Mar 13, 2013 | Issued |
Array
(
[id] => 9739288
[patent_doc_number] => 20140275007
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-18
[patent_title] => 'OXAMAZIN ANTIBIOTICS'
[patent_app_type] => utility
[patent_app_number] => 13/829304
[patent_app_country] => US
[patent_app_date] => 2013-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13684
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13829304
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/829304 | OXAMAZIN ANTIBIOTICS | Mar 13, 2013 | Abandoned |
Array
(
[id] => 10705344
[patent_doc_number] => 20160051491
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-02-25
[patent_title] => 'NOVEL USE OF PINOSYLVIN FOR ANGIOGENESIS PROMOTION'
[patent_app_type] => utility
[patent_app_number] => 14/768110
[patent_app_country] => US
[patent_app_date] => 2013-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5706
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14768110
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/768110 | NOVEL USE OF PINOSYLVIN FOR ANGIOGENESIS PROMOTION | Mar 12, 2013 | Abandoned |
Array
(
[id] => 8927628
[patent_doc_number] => 20130183388
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-07-18
[patent_title] => 'Novel IDO Inhibitors and Methods of Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 13/777383
[patent_app_country] => US
[patent_app_date] => 2013-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6893
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13777383
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/777383 | Novel IDO Inhibitors and Methods of Use Thereof | Feb 25, 2013 | Abandoned |
Array
(
[id] => 10202685
[patent_doc_number] => 20150087674
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-03-26
[patent_title] => 'COMPOSITIONS AND METHODS FOR THE TREATMENT OF SEVERE PAIN'
[patent_app_type] => utility
[patent_app_number] => 14/399201
[patent_app_country] => US
[patent_app_date] => 2013-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8957
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14399201
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/399201 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF SEVERE PAIN | Feb 22, 2013 | Abandoned |
Array
(
[id] => 9686615
[patent_doc_number] => 20140243381
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-28
[patent_title] => 'FURYL AND THIENYL TRIAZOLE DERIVATIVES AND THERAPEUTIC USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/774231
[patent_app_country] => US
[patent_app_date] => 2013-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5702
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13774231
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/774231 | Furyl and thienyl triazole derivatives and therapeutic uses thereof | Feb 21, 2013 | Issued |
Array
(
[id] => 9865380
[patent_doc_number] => 20150045400
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-02-12
[patent_title] => 'RITONAVIR COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 14/382075
[patent_app_country] => US
[patent_app_date] => 2013-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2859
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14382075
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/382075 | RITONAVIR COMPOSITIONS | Feb 17, 2013 | Abandoned |
Array
(
[id] => 10248506
[patent_doc_number] => 20150133503
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-05-14
[patent_title] => 'PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING TUBERCULOSIS'
[patent_app_type] => utility
[patent_app_number] => 14/382548
[patent_app_country] => US
[patent_app_date] => 2013-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 7342
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14382548
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/382548 | Pharmaceutical composition for preventing or treating tuberculosis | Feb 12, 2013 | Issued |
Array
(
[id] => 9331093
[patent_doc_number] => 20140057875
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-27
[patent_title] => 'CRYSTALLIZATION METHOD AND BIOAVAILABILITY'
[patent_app_type] => utility
[patent_app_number] => 13/766034
[patent_app_country] => US
[patent_app_date] => 2013-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 39
[patent_no_of_words] => 10862
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13766034
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/766034 | Crystallization method and bioavailability | Feb 12, 2013 | Issued |
Array
(
[id] => 10234369
[patent_doc_number] => 20150119363
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-04-30
[patent_title] => 'METHODS OF TREATING BACTERIAL INFECTIONS'
[patent_app_type] => utility
[patent_app_number] => 14/377163
[patent_app_country] => US
[patent_app_date] => 2013-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 47610
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14377163
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/377163 | METHODS OF TREATING BACTERIAL INFECTIONS | Feb 10, 2013 | Abandoned |
Array
(
[id] => 10844612
[patent_doc_number] => 08871789
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-10-28
[patent_title] => 'Method of preventing or treating viral infection'
[patent_app_type] => utility
[patent_app_number] => 13/747406
[patent_app_country] => US
[patent_app_date] => 2013-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 60
[patent_figures_cnt] => 61
[patent_no_of_words] => 12602
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13747406
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/747406 | Method of preventing or treating viral infection | Jan 21, 2013 | Issued |
Array
(
[id] => 8830076
[patent_doc_number] => 20130131121
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-23
[patent_title] => 'ANTI-VIRAL AGENT'
[patent_app_type] => utility
[patent_app_number] => 13/744913
[patent_app_country] => US
[patent_app_date] => 2013-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5019
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13744913
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/744913 | ANTI-VIRAL AGENT | Jan 17, 2013 | Abandoned |
Array
(
[id] => 8951119
[patent_doc_number] => 20130196900
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-01
[patent_title] => 'ENHANCEMENT OF INNATE RESISTANCE TO INFECTION'
[patent_app_type] => utility
[patent_app_number] => 13/744931
[patent_app_country] => US
[patent_app_date] => 2013-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 11803
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13744931
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/744931 | ENHANCEMENT OF INNATE RESISTANCE TO INFECTION | Jan 17, 2013 | Abandoned |